Neutropenia in the age of genetic testing: Advances and challenges

Authors:

Abstract
Identification of genetic causes of neutropenia informs precision medicine approaches to medical management and treatment. Accurate diagnosis of genetic neutropenia disorders informs treatment options, enables risk stratification, cancer surveillance, and attention to associated medical complications. The rapidly expanding genetic testing options for the evaluation of neutropenia have led to exciting advances but also new challenges. This review provides a practical guide to germline genetic testing for neutropenia.
Funding Information
  • National Heart, Lung, and Blood Institute (T32 HL007574‐36)
  • National Institute of Allergy and Infectious Diseases (R24 AI049393)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R24 DK099808)

This publication has 97 references indexed in Scilit: